Literature DB >> 9209076

Time course of pronuclear deoxyribonucleic acid synthesis in parthenogenetically activated bovine oocytes.

E Soloy1, J Kanka, D Viuff, S D Smith, H Callesen, T Greve.   

Abstract

The progress of pronuclear DNA synthesis was monitored by the radioactive precursor 3H-thymidine during the first cell cycle of parthenogenetically activated bovine oocytes. Bovine oocytes were exposed to Ca2+ ionophore A23187 at 24, 30, or 36 h after the onset of in vitro maturation. Young 24-h oocytes were subsequently cultured for 6 h in the protein synthesis inhibitor, cycloheximide (CHX), to ensure similar rates of activation (96-100%) and pronuclear formation (93-97%) among all groups of oocytes. Subsequent autoradiographic experiments revealed a slightly, but not significantly, accelerated start of DNA synthesis in aged (36 h) oocytes. Maximum levels of DNA labeling were reached within 4 h regardless of oocyte maturation age and persisted for 4 h in 30-h oocytes compared to 2 h in 36-h and 24-h oocytes. The period of DNA synthesis lasted for a total of 12-14 h in all groups of oocytes, and the duration of S-phase was less than 6 h. Since rates of pronuclear formation (58%) and labeling (58%) corresponded to each other, it is argued that only a fully developed pronucleus can synthesize DNA. Oocyte labeling performed in the presence of CHX revealed the capability of CHX to inhibit DNA synthesis up to 8 h postactivation. Removal of CHX by washing when the majority (94%) of oocytes had formed a fully developed pronucleus (at 8 h postactivation) led to the synchronous start of DNA synthesis within 1.5-2 h post-CHX culture. This concomitantly defined the time required for synthesis of vital proteins needed for the entry into S-phase and/or DNA replication. The prolonged exposure of activated oocytes to CHX (10-12 h) negatively affected the pattern of DNA synthesis. The start of DNA synthesis was postponed and reduced pronuclear labeling was observed. In addition, CHX-treated oocytes often exhibited a characteristic punctate pattern of pronuclear labeling in which silver grains were accumulated into clusters. In conclusion, the present results provide knowledge about timing and a possible synchronization of DNA synthesis in parthenogenetically activated bovine oocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209076     DOI: 10.1095/biolreprod57.1.27

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  5 in total

1.  Effects of different activation protocols on cleavage rate and blastocyst production of caprine oocytes.

Authors:  J Pathak; S D Kharche; A Goel
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

2.  Development and calcium level changes in pre-implantation porcine nuclear transfer embryos activated with 6-DMAP after fusion.

Authors:  Gi-Sun Im; Melissa Samuel; Liangxue Lai; Yanhong Hao; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2007-09       Impact factor: 2.609

3.  Epigenetic modification with trichostatin A does not correct specific errors of somatic cell nuclear transfer at the transcriptomic level; highlighting the non-random nature of oocyte-mediated reprogramming errors.

Authors:  Sayyed Morteza Hosseini; Isabelle Dufort; Julie Nieminen; Fariba Moulavi; Hamid Reza Ghanaei; Mahdi Hajian; Farnoosh Jafarpour; Mohsen Forouzanfar; Hamid Gourbai; Abdol Hossein Shahverdi; Mohammad Hossein Nasr-Esfahani; Marc-André Sirard
Journal:  BMC Genomics       Date:  2016-01-04       Impact factor: 3.969

4.  Parthenogenetic bovine embryos secrete type I interferon capable of stimulating ISG15 in luteal cell culture.

Authors:  Alessandra Bridi; Kalyne Bertolin; Vitor B Rissi; Lady K S Mujica; Werner G Glanzner; Mariana P de Macedo; Fabio V Comim; Paulo B D Gonçalves; Alfredo Q Antoniazzi
Journal:  Anim Reprod       Date:  2018-12-05       Impact factor: 1.807

5.  The Effect of the Duration of In Vitro Maturation (IVM) on Parthenogenetic Development of Ovine Oocytes.

Authors:  Abolfazl Shirazi; Amin Bahiraee; Ebrahim Ahmadi; Hassan Nazari; Banafsheh Heidari; Sara Borjian
Journal:  Avicenna J Med Biotechnol       Date:  2009-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.